Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study)

12 month results of a randomized, double-blind, placebo-controlled phase 2 trial

M. R. Rigby, L. A. DiMeglio, M. S. Rendell, E. I. Felner, J. M. Dostou, S. E. Gitelman, C. M. Patel, K. J. Griffin, E. Tsalikian, P. A. Gottlieb, C. J. Greenbaum, N. A. Sherry, W. V. Moore, R. Monzavi, S. M. Willi, P. Raskin, A. Moran, W. E. Russell, A. Pinckney, L. Keyes-Elstein & 7 others M. Howell, S. Aggarwal, N. Lim, D. Phippard, G. T. Nepom, J. McNamara, M. R. Ehlers

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)S81-S82
JournalDiabetes Technology and Therapeutics
Volume17
DOIs
StatePublished - Feb 1 2015

All Science Journal Classification (ASJC) codes

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medical Laboratory Technology

Cite this

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study) : 12 month results of a randomized, double-blind, placebo-controlled phase 2 trial. / Rigby, M. R.; DiMeglio, L. A.; Rendell, M. S.; Felner, E. I.; Dostou, J. M.; Gitelman, S. E.; Patel, C. M.; Griffin, K. J.; Tsalikian, E.; Gottlieb, P. A.; Greenbaum, C. J.; Sherry, N. A.; Moore, W. V.; Monzavi, R.; Willi, S. M.; Raskin, P.; Moran, A.; Russell, W. E.; Pinckney, A.; Keyes-Elstein, L.; Howell, M.; Aggarwal, S.; Lim, N.; Phippard, D.; Nepom, G. T.; McNamara, J.; Ehlers, M. R.

In: Diabetes Technology and Therapeutics, Vol. 17, 01.02.2015, p. S81-S82.

Research output: Contribution to journalComment/debate

Rigby, MR, DiMeglio, LA, Rendell, MS, Felner, EI, Dostou, JM, Gitelman, SE, Patel, CM, Griffin, KJ, Tsalikian, E, Gottlieb, PA, Greenbaum, CJ, Sherry, NA, Moore, WV, Monzavi, R, Willi, SM, Raskin, P, Moran, A, Russell, WE, Pinckney, A, Keyes-Elstein, L, Howell, M, Aggarwal, S, Lim, N, Phippard, D, Nepom, GT, McNamara, J & Ehlers, MR 2015, 'Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomized, double-blind, placebo-controlled phase 2 trial', Diabetes Technology and Therapeutics, vol. 17, pp. S81-S82. https://doi.org/10.1089/dia.2015.1510
Rigby, M. R. ; DiMeglio, L. A. ; Rendell, M. S. ; Felner, E. I. ; Dostou, J. M. ; Gitelman, S. E. ; Patel, C. M. ; Griffin, K. J. ; Tsalikian, E. ; Gottlieb, P. A. ; Greenbaum, C. J. ; Sherry, N. A. ; Moore, W. V. ; Monzavi, R. ; Willi, S. M. ; Raskin, P. ; Moran, A. ; Russell, W. E. ; Pinckney, A. ; Keyes-Elstein, L. ; Howell, M. ; Aggarwal, S. ; Lim, N. ; Phippard, D. ; Nepom, G. T. ; McNamara, J. ; Ehlers, M. R. / Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study) : 12 month results of a randomized, double-blind, placebo-controlled phase 2 trial. In: Diabetes Technology and Therapeutics. 2015 ; Vol. 17. pp. S81-S82.
@article{ce4d7621cf60417e9c019183803fd2e3,
title = "Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomized, double-blind, placebo-controlled phase 2 trial",
author = "Rigby, {M. R.} and DiMeglio, {L. A.} and Rendell, {M. S.} and Felner, {E. I.} and Dostou, {J. M.} and Gitelman, {S. E.} and Patel, {C. M.} and Griffin, {K. J.} and E. Tsalikian and Gottlieb, {P. A.} and Greenbaum, {C. J.} and Sherry, {N. A.} and Moore, {W. V.} and R. Monzavi and Willi, {S. M.} and P. Raskin and A. Moran and Russell, {W. E.} and A. Pinckney and L. Keyes-Elstein and M. Howell and S. Aggarwal and N. Lim and D. Phippard and Nepom, {G. T.} and J. McNamara and Ehlers, {M. R.}",
year = "2015",
month = "2",
day = "1",
doi = "10.1089/dia.2015.1510",
language = "English",
volume = "17",
pages = "S81--S82",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",

}

TY - JOUR

T1 - Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study)

T2 - 12 month results of a randomized, double-blind, placebo-controlled phase 2 trial

AU - Rigby, M. R.

AU - DiMeglio, L. A.

AU - Rendell, M. S.

AU - Felner, E. I.

AU - Dostou, J. M.

AU - Gitelman, S. E.

AU - Patel, C. M.

AU - Griffin, K. J.

AU - Tsalikian, E.

AU - Gottlieb, P. A.

AU - Greenbaum, C. J.

AU - Sherry, N. A.

AU - Moore, W. V.

AU - Monzavi, R.

AU - Willi, S. M.

AU - Raskin, P.

AU - Moran, A.

AU - Russell, W. E.

AU - Pinckney, A.

AU - Keyes-Elstein, L.

AU - Howell, M.

AU - Aggarwal, S.

AU - Lim, N.

AU - Phippard, D.

AU - Nepom, G. T.

AU - McNamara, J.

AU - Ehlers, M. R.

PY - 2015/2/1

Y1 - 2015/2/1

UR - http://www.scopus.com/inward/record.url?scp=84923112610&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923112610&partnerID=8YFLogxK

U2 - 10.1089/dia.2015.1510

DO - 10.1089/dia.2015.1510

M3 - Comment/debate

VL - 17

SP - S81-S82

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

ER -